Metallopanstimulin as a marker for head and neck cancer

World Journal of Surgical Oncology

Volumn 2, Issue , 2004, Pages

  Stack Jr , Brendan C ^a   Hollenbeak, Christopher S ^a,b   Lee, Christopher M ^c   Dunphy, Frank R ^d   Lowe, Val J ^e   Hamilton, Paul D ^f  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b LEHIGH VALLEY HOSPITAL   (United States)

^c UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e MAYO CLINIC   (United States)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CARBOPLATIN; METALLOPANSTIMULIN; PACLITAXEL; RIBOSOME PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BLOOD SAMPLING; CANCER PATIENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEAD AND NECK CANCER; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT DEPARTMENT; PROSPECTIVE STUDY; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY; STATISTICAL ANALYSIS;

EID: 13844297747     PISSN: 14777819     EISSN: None     Source Type: Journal    
DOI: 10.1186/1477-7819-2-45     Document Type: Article

References (29)

1. Million RR, Cassisi NJ: Management of Head and Neck Cancer, 2nd ed. Philadelphia: JB Lippencott Co; 1993:75-142.
2. Rockledge PA: The complete library of NCCN clinical practice guidelines in oncology. National Comprehensive Cancer Network, Inc 2003.
3. Agrawal A, deSilva BW, Buckley BM, Schuller DE: Role of the physician versus the patient in the detection of recurrent disease following treatment for head and neck cancer. Laryngoscope 2004, 114:232-235.
4. Dietz A, Rudat V, Conradt C, Weidauer H, Ho A, Moehler T: Prognostic relevance of serum levels of the angiogenic peptide bFGF in advanced carcinoma of the head and neck treated by primary radiochemotherapy. Head Neck 2000, 22:666-673.
5. Quon H, Liu FF, Cummings BJ: Potential molecular markers in head and neck squamous cell carcinomas. Head Neck 2001, 23:147-159.
6. Teknos TN, Cox C, Yoo S, Chepeha DN, Wolf GT, Bradford CR, Carey TE, Fisher SG: Elevated serum vascular endothelial growth factor and decreased survival in advanced laryngeal carcinoma. Head Neck 2002, 24:1004-1011.
7. Schmidt M, Grunsfelder P: Urokinase-type plasminogen activator expression and proliferation stimulation in head and neck squamous cell carcinoma in vitro and in situ. Arch Otolaryngol Head Neck Surg 2001, 127:679-682.
8. Tartour E, Mosseri V, Jouffroy T, Deneux L, Jaulerry C, Brunin F, Fridman WH, Rodriguez J: Serum soluble interleukin-2 receptor concentrations as an independent prognostic marker in head and neck cancer. Lancet 2001, 357:1263-1264.
9. Fernandez-Pol JA, Klos DJ, Hamilton PD: A growth factor-inducible gene encodes a novel nuclear protein with zinc finger structure. J Biol Chem 1993, 268:21198-21204.
10. Fernandez-Pol JA, Klos DJ, Hamilton PD: Metallopanstimulin gene product produced in a baculovirus expression system is a nuclear phosphoprotein that binds to DNA. Cell Growth Differ 1994, 5: 11-825.
11. Ganger DR, Hamilton PD, Klos DJ, Jakate S, McChesney L, Fernandez-Pol JA: Differential expression of metallopanstimulin/S27 ribosomal protein in hepatic regeneration and neoplasia. Cancer Detect Prev 2001, 25:231-246.
12. Fernandez-Pol JA, Fletcher JW, Hamilton PD, Klos DJ: Expression of metallopanstimulin and oncogenesis in human prostatic carcinoma. Anticancer Res 1997, 17:1519-1530.
13. Ganger DR, Hamilton PD, Fletcher JW, Fernandez-Pol JA: Metallopanstimulin is overexpressed in a patient with colonic carcinoma. Anticancer Res 1997, 17:1993-1999.
14. Fernandez-Pol JA: Metallopanstimulin as a novel tumor marker in sera of patients with various types of common cancers: implications for prevention and therapy. Anticancer Res 1996, 16:2177-2185.
15. Santa Cruz DJ, Hamilton PD, Klos DJ, Fernandez-Pol JA: Differential expression of metallopanstimulin/S27 ribosomal protein in melanocytic lesions of the skin. J Cutan Pathol 1997, 24: 33-542.
16. Atsuta Y, Aoki N, Sato K, Oikawa K, Nochi H, Miyokawa N, Hirata S, Kimura S, Sasjima T, Katagira M: Identification of metallopanstimulin-1 as a member of a tumor associated antigen in patients with breast cancer. Cancer Letters 2002, 182: 01-107.
17. Wool IG: Extraribosomal functions of ribosomal proteins. Trends Biochem Sci 1996, 21:164-165.
18. Wool IG, Chan YL, Gluck A: Structure and evolution of mammalian ribosomal proteins. Biochem Cell Biol 1995, 73: 33-947.
19. Kasai H, Nadano D, Hidaka E, Higuchi K, Kawakubo M, Sato T-A, Nakayama J: Differential expresión of ribosomal proteins in human normal and neoplastic colorectum. J Histochem Cytochem 2003, 51:567-573.
20. Naora H, Naora H: Involvement of ribosomal proteins in regulating cell growth and apoptosis: Translational modulation or recruitment for extraribosomal activity? Immunol Cell Biol 1999, 77:197-205.
21. Chan YL, Olvera J, Paz V, Wool IG: The primary structures of rat ribosomal proteins S3a (the V-Fos transformation effector) and of S3b. Biochem Biophys Res Commun 1996, 228:141-147.
22. Chan YL, Diaz JJ, Denoroy L, Madjar JJ, Wool IG: The primary structure of rat ribosomal protein L10: relationship to a Junbinding protein and to a putative Wilms' tumor suppressor. Biochem Biophys Res Commun 1996, 225:952-956.
23. Fernandez-Pol JA, Hamilton PD, Klos DJ: Essential viral and cellular zinc and iron containing metalloproteins as targets for novel antiviral and anticancer agents: implications for prevention and therapy of viral diseases and cancer. Anticancer Res 2001, 21:931-957.
24. Stack BC Jr, Dalsaso TA, Lee C Jr, Lowe VJ, Hamilton PD, Fletcher JW, Fernandez-Pol JA: Overexpression of MPS antigens by squamous cell carcinomas of the head and neck: immunohistochemical and serological correlation with FDG positron emission tomography. Anticancer Res 1999, 19:5503-5510.
25. Lowe VJ, Boyd JH, Dunphy FR, Kim H, Dunleavy T, Collins BT, Martin D, Stack BC Jr, Hollenbeak C, Fletcher JW: Surveillance for recurrent head and neck cancer using positron emission tomography. J Clin Oncol 2000, 18:651-658.
26. Hollenbeak CS, Lowe VJ, Stack BC Jr: The cost-effectiveness of fluorodeoxyglucose 18-F positron emission tomography in the N0 neck. Cancer 2001, 92:2341-2348.
27. Wadsworth JT, Somers KD, Cazares LH, Adam B-L, Stack BC Jr, Wright GL Jr, Semmes OJ: Serum protein profiles to identify head and neck cancer. Clin Cancer Res 2004, 10:1625-1632.
28. Wadsworth JT, Somers KD, Stack BC Jr, Cazares LH, Malik G, Adam BL, Wright GL Jr, Semmes OJ: Identification of patients with head and neck cancer using serum protein profiles. Arch Otolaryngol Head Neck Surg 2004, 130:98-104.
29. Lee WJ, Keefer K, Hollenbeak CS, Stack BC Jr: A new assay to screen for head and neck squamous cell carcinoma using the tumor marker metallopanstimulin (MPS). Otolaryngol Head Neck Surg 2004, 131:466-471.